Sign In
Buy ARVN
$8.03
-0.270 (-3.25%)
At Close: Jul 31, 2026
Healthcare Faces A Contagion
02:36pm, Thursday, 27'th Feb 2020
Fear mounts as investors brace for a viral outbreak in the US. Volatility to remain high as Covid-19 virus remains an unknown threat. Impact on earnings outlook
Arvinas (NASDAQ:ARVN) Stock Rating Lowered by Zacks Investment Research
11:14am, Thursday, 27'th Feb 2020
Arvinas (NASDAQ:ARVN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Arv
Arvinas Inc (NASDAQ:ARVN) Short Interest Update
10:00am, Thursday, 27'th Feb 2020
Arvinas Inc (NASDAQ:ARVN) was the target of a significant decrease in short interest in February. As of February 14th, there was short interest totalling 1,590,000 shares, a decrease of 25.4% from the
Analysts Expect Arvinas Inc (NASDAQ:ARVN) Will Announce Earnings of -$0.56 Per Share
11:30am, Monday, 24'th Feb 2020
Wall Street analysts forecast that Arvinas Inc (NASDAQ:ARVN) will report earnings per share of ($0.56) for the current quarter, according to Zacks Investment Research. Four analysts have made estimate
Dokter: Masyarakat agar kenali prinsip "ESSE" pada HIV/AIDS
11:39am, Thursday, 20'th Feb 2020
Dokter Ketut Suryana, Sp.PD-KAI FINASIM konsultan pada klinik VCT Merpati RSUD Wangaya Denpasar mengajak masyarakat untuk mengenali prinsip Exit, Survive, ...
Arvinas (NASDAQ:ARVN) Downgraded by Zacks Investment Research to Hold
10:58am, Monday, 17'th Feb 2020
Zacks Investment Research downgraded shares of Arvinas (NASDAQ:ARVN) from a buy rating to a hold rating in a research note issued to investors on Thursday morning, Zacks.com reports. According to Zack
Arvinas (NASDAQ:ARVN) Shares Down 6.3%
03:47pm, Sunday, 09'th Feb 2020
Arvinas Inc (NASDAQ:ARVN)’s stock price was down 6.3% during mid-day trading on Friday . The company traded as low as $49.25 and last traded at $51.05, approximately 761,299 shares traded hands duri
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
12:47pm, Thursday, 06'th Feb 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced gr
Biotechs Feel The Bern
02:30pm, Monday, 03'rd Feb 2020
Healthcare is entering a period where election cycle impact will grow. The Medicare for All healthcare plan will begin to get factored based on the success of t
BidaskClub Downgrades Arvinas (NASDAQ:ARVN) to Buy
12:04pm, Monday, 03'rd Feb 2020
Arvinas (NASDAQ:ARVN) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Saturday, BidAskClub reports. Several othe
Shareholders Are Thrilled That The Arvinas (NASDAQ:ARVN) Share Price Increased 137%
11:00am, Monday, 03'rd Feb 2020
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...
Arvinas (NASDAQ:ARVN) Stock Rating Reaffirmed by BMO Capital Markets
10:30am, Saturday, 01'st Feb 2020
Arvinas (NASDAQ:ARVN)‘s stock had its “outperform” rating restated by research analysts at BMO Capital Markets in a research report issued to clients and investors on Thursday, The Fly reports.
